| Literature DB >> 22197012 |
Huynh Thi Loan1, Janet Parry, Nguyen Thi Ngoc Nga, Lam Minh Yen, Nguyen Thien Binh, Tran Thi Diem Thuy, Nguyen Minh Duong, James I Campbell, Louise Thwaites, Jeremy J Farrar, Christopher M Parry.
Abstract
Healthcare-associated pneumonia (HCAP) is a common complication in patients with severe tetanus. Nursing tetanus patients in a semi-recumbent body position could reduce the incidence of HCAP. In a randomised controlled trial we compared the occurrence of HCAP in patients with severe tetanus nursed in a semi-recumbent (30°) or supine position. A total of 229 adults and children (aged ≥1 year) with severe tetanus admitted to hospital in Vietnam, were randomly assigned to a supine (n=112) or semi-recumbent (n=117) position. For patients maintaining their assigned positions and in hospital for>48h there was no significant difference between the two groups in the frequency of clinically suspected pneumonia [22/106 (20.8%) vs 26/104 (25.0%); p=0.464], pneumonia rate/1000 intensive care unit days (13.9 vs 14.6; p=0.48) and pneumonia rate/1000 ventilated days (39.2 vs 38.1; p=0.72). Mortality in the supine patients was 11/112 (9.8%) compared with 17/117 (14.5%) in the semi-recumbent patients (p=0.277). The overall complication rate [57/112 (50.9%) vs 76/117 (65.0%); p=0.03] and need for tracheostomy [51/112 (45.5%) vs 69/117 (58.9%); p=0.04) was greater in semi-recumbent patients. Semi-recumbent body positioning did not prevent the occurrence of HCAP in severe tetanus patients.Entities:
Mesh:
Year: 2011 PMID: 22197012 PMCID: PMC3368426 DOI: 10.1016/j.trstmh.2011.10.010
Source DB: PubMed Journal: Trans R Soc Trop Med Hyg ISSN: 0035-9203 Impact factor: 2.184
Figure 1CONSORT flow chart demonstrating recruitment of patients to the study. HCAP: healthcare-associated pneumonia; ICU: intensive care unit.
Comparison of the admission characteristics of all patients recruited into the study
| Supine | Semi-recumbent | p-value | |
|---|---|---|---|
| Mean (range) age (years) | 34 (9–67) | 38 (13–69) | 0.159 |
| Male | 87 (77.7%) | 96 (82.1%) | 0.409 |
| Transferred from another hospital | 84 (75.0%) | 91 (77.7%) | 0.621 |
| Prior antibiotics | 20 (17.9%) | 37 (31.6%) | 0.016 |
| Underlying medical condition | 10 (8.9%) | 7 (6.0%) | 0.395 |
| Injecting drug user | 6 (5.4%) | 5 (4.3%) | 0.701 |
| Smoker | 52 (46.4%) | 61 (52.1%) | 0.388 |
| Vaccination as a child | 5 (4.5%) | 6 (5.1%) | 0.814 |
| Entry site | |||
| Foot | 50 (44.6%) | 59 (50.4%) | 0.381 |
| Unknown | 16 (14.3%) | 21 (17.9%) | 0.452 |
| Injection | 6 (5.4%) | 4 (3.4%) | 0.473 |
| Other | 40 (35.7%) | 33 (28.2%) | 0.223 |
| Mean (range) incubation period (days) | 7 (4–13) | 7 (4–23) | 0.099 |
| Mean (range) period of onset (h) | 24 (12–79) | 48 (12–96) | 0.689 |
| History of spasms | 51 (45.5%) | 50 (42.7%) | 0.670 |
| History of sweating | 12 (10.7%) | 18 (15.4%) | 0.295 |
| Generalised spasms | 110 (98.2%) | 110 (94.0%) | 0.172 |
| Mean (range) tetanus severity score | 2.31 (−6 to 25) | 1.91 (−5 to 22) | 0.582 |
| Mean (range) white cell count (×109/l) | 9.5 (5.3–14.7) | 8.4 (5.5–14.7) | 0.503 |
| Mean (range) creatinine (mg/%) | 1.0 (0.7–1.3) | 1.0 (0.7–1.4) | 0.359 |
Data are number (%) unless otherwise indicated.
Clinical and microbiological pneumonia in 229 study patients
| Supine | Semi-recumbent | Odds ratio (95% CI) | p-value | |
|---|---|---|---|---|
| (n = 112) | (n = 117) | |||
| Patients with clinical diagnosis of pneumonia | 26 (23.2%) | 29 (24.8%) | 0.92 (0.48–1.76) | 0.78 |
| Patients with microbiological diagnosis of pneumonia | 19 (17.0%) | 26 (22.2%) | 0.72 (0.35–1.45) | 0.32 |
| Organisms isolated | ||||
| | 8 | 11 | ||
| | 10 (1) | 11 (1) | ||
| | 9 (1) | 9 | ||
| | 3 | 3 | ||
| | 3 | 1 | ||
| | 1 | 0 | ||
| Patients who developed HCAP2 (>48 h after admission to hospital) | 22/106 (20.8%) | 26/104 (25.0%) | 0.79 (0.39–1.57) | 0.46 |
| Patients with a tracheostomy who developed HCAP | 22/49 (44.9%) | 26/59 (44.1%) | 1.03 (0.45–2.38) | 0.93 |
| Ventilated patients who developed HCAP | 21/37 (56.8%) | 24/44 (54.5%) | 1.09 (0.41–2.90) | 0.84 |
| HCAP rate/1000 ICU days | 13.9 | 14.6 | 0.48 | |
| HCAP rate/1000 ventilated days | 39.2 | 38.1 | 0.72 | |
| Mean (range) cost of antimicrobials for pneumonia treatment (US$/patient) | 228 (56–611) | 215 (9–933) | 0.84 | |
Data are number (%) unless otherwise indicated.
HCAP: healthcare-associated pneumonia; ICU: intensive care unit.
Organisms isolated from blood, or from the non-bronchoscopic lavage (≥105 CFU/ml). Number in parentheses refers to the isolation of the organism from blood culture.
Outcome in 229 study patients
| Supine | Semi-recumbent | Odds ratio (95% CI) | p-value | |
|---|---|---|---|---|
| (n = 112) | (n = 117) | |||
| Any complication | 57 (50.9%) | 76 (65.0%) | 0.56 (0.32–0.98) | 0.031 |
| Tracheostomy used | 51 (45.5%) | 69 (58.9%) | 0.58 (0.33–1.02) | 0.042 |
| Mechanical ventilation | 39 (34.8%) | 53 (45.2%) | 0.65 (0.37–1.14) | 0.106 |
| Gastrointestinal bleed | 30 (26.8%) | 34 (29.1%) | 0.89 (0.48–1.66) | 0.701 |
| Pneumonia | 26 (23.2%) | 29 (24.8%) | 0.92 (0.48–1.76) | 0.781 |
| Autonomic instability | 14 (12.5%) | 17 (14.5%) | 0.84 (0.37–1.91) | 0.654 |
| Episode of hypotension | 11 (9.8%) | 20 (17.1%) | 0.53 (0.22–1.23) | 0.108 |
| Urinary tract infection | 12 (10.7%) | 7 (6.0%) | 1.89 (0.66–5.55) | 0.194 |
| Bacteraemia | 8 (7.1%) | 6 (5.1%) | 1.21 (0.38–3.86) | 0.525 |
| Wound infection | 5 (4.5%) | 11 (9.4%) | 0.45 (0.12–1.47) | 0.143 |
| Pressure sore | 5 (4.5%) | 7 (6.0%) | 0.73 (0.18–2.79) | 0.606 |
| Renal failure | 1 (0.9%) | 2 (1.7%) | 0.52 (0.01–1.11) | 1.00 |
| Nasogastric tube used | 77 (68.8%) | 93 (79.5%) | 0.57 (0.30–1.80) | 0.063 |
| Mean (range) dose of benzodiazepine used (mg/kg/day) | 0.98 (0.50–1.46) | 0.89 (0.44–1.47) | 0.482 | |
| Mean (range) dose of pipecuronium used (mg/kg/day) | 0.41 (0.04–1.08) | 0.59 (0.20–0.97) | 0.818 | |
| Stress ulcer prophylaxis given | 26 (23.2%) | 28 (23.9%) | 0.96 (0.50–1.85) | 0.898 |
| Mean (range) duration on ICU (days) | 15 (2–66) | 17 (1–108) | 0.197 | |
| Mean (range) duration in hospital (days) | 27 (3–121) | 29 (3–108) | 0.468 | |
| Mortality | 11 (9.8%) | 17 (14.5%) | 0.64 (0.27–1.53) | 0.277 |
Data are number (%) unless otherwise indicated.
ICU: intensive care unit.